A photo of Tracy Glauser.

Tracy A. Glauser, MD


  • Associate Director, Cincinnati Children's Research Foundation
  • Professor, UC Department of Pediatrics

About

Biography

Tracy A. Glauser, MD, is associate director of the Cincinnati Children's Research Foundation and professor of pediatrics in the University of Cincinnati College of Medicine. Dr. Glauser received his medical degree, cum laude, from Jefferson Medical College in Philadelphia, PA. He completed his residency in pediatrics at the John Hopkins Hospital in Baltimore, MD, and fellowship in child neurology at The Children’s Hospital of Philadelphia, University of Pennsylvania in Philadelphia, PA. Dr. Glauser completed a National Institute of Neurological Disorders and Stroke research fellowship in pediatric neurology and was a fellow in epilepsy and electroencephalography at St. Louis Children’s Hospital, Washington University School of Medicine in St. Louis, Missouri.

Dr. Glauser has authored and co-authored more than 130 articles and book chapters, been involved with the development of six evidence-based guidelines about epilepsy therapy and given over 150 invited lectures throughout the world. He has been the principal investigator on multiple NIH grants. Currently, Dr. Glauser directs the NIH funded Childhood Absence Epilepsy clinical trial involving 32 pediatric centers around the United States. Dr. Glauser's fields of expertise are pediatric neurology, pediatric epilepsy, clinical pharmacology and pharmacogenetics.

MD: Jefferson Medical College, Philadelphia, PA, 1985.

Residency: Johns Hopkins Hospital, Baltimore, MD.

Fellowship: St. Louis Children's Hospital, St. Louis, MO.

Certification: Pediatrics, 1990; Neurology (with special competence in child neurology), 1991.

Interests

Epilepsy; pharmacogenetics; clinical pharmacology

Services and Specialties

Neurology, Epilepsy

Interests

Clinical pharmacology; pharmacogenetics; antiepileptic clinical trials

Research Areas

Neurology, Clinical Pharmacology, Genomics

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Selected

Development of information sharing in language neocortex in childhood-onset drug-resistant epilepsy. Arya, R; Ervin, B; Wilson, JA; Byars, AW; Rozhkov, L; Buroker, J; Horn, PS; Scholle, C; Fujiwara, H; Greiner, HM; Leach, JL; Rose, DF; Mangano, FT; Glauser, TA; Holland, KD. Epilepsia. 2019; 60:393-405.

Selected

Pretreatment behavior and subsequent medication effects in childhood absence epilepsy. Shinnar, RC; Shinnar, S; Cnaan, A; Clark, P; Dlugos, D; Hirtz, DG; Hu, F; Liu, C; Masur, D; Weiss, EF; Glauser, TA; Study, CA E. Neurology. 2017; 89:1698-1706.

Selected

Pretreatment seizure semiology in childhood absence epilepsy. Kessler, SK; Shinnar, S; Cnaan, A; Dlugos, D; Conry, J; Hirtz, DG; Hu, F; Liu, C; Mizrahi, EM; Moshe, SL; Clark, P; Glauser, TA; Childhood, AE S G. Neurology. 2017; 89:673-679.

Selected

Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. Glauser, TA; Holland, K; O'Brien, VP; Keddache, M; Martin, LJ; Clark, PO; Cnaan, A; Dlugos, D; Hirtz, DG; Shinnar, S; Grabowski, G; Study, CA E. Annals of Neurology. 2017; 81:444-453.

Selected

Second monotherapy in childhood absence epilepsy. Cnaan, A; Shinnar, S; Arya, R; Adamson, PC; Clark, PO; Dlugos, D; Hirtz, DG; Masur, D; Glauser, TA; Study, CA E. Neurology. 2017; 88:182-190.

Selected

Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trial. Shinnar, S; Cnaan, A; Hu, F; Clark, P; Dlugos, D; Hirtz, DG; Masur, D; Mizrahi, EM; Moshe, SL; Glauser, TA; Study, CA E. Neurology. 2015; 85:1108-1114.

Selected

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Glauser, TA; Cnaan, A; Shinnar, S; Hirtz, DG; Dlugos, D; Masur, D; Clark, PO; Adamson, PC; Study, CA E. Epilepsia. 2013; 54:141-155.

Selected

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. Glauser, TA; Cnaan, A; Shinnar, S; Hirtz, DG; Dlugos, D; Masur, D; Clark, PO; Capparelli, EV; Adamson, PC; Study, CA E. The New England Journal of Medicine. 2010; 362:790-799.

Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes. Berkovic, SF; Neale, BM; Zsurka, G; Zizovic, M; Zimprich, F; Zara, F; Zahnert, F; Zagaglia, S; Yücesan, E; Yolken, R; Ramirez-Hamouz, B; Ragona, F; Rademacher, A; Privitera, M. Nature Neuroscience. 2024; 27:1864-1879.

Short-Term Impact of Seizures and Mitigation Opportunities. Glauser, T; Becker, DA; Long, L; Detyniecki, K; Penovich, P; Sirven, J; Peters, JM; Rabinowicz, AL; Carrazana, E. Current Neurology and Neuroscience Reports. 2024; 24:303-314.

From the Blog

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

4.6
Overall Patient Rating